MSB 2.98% $1.47 mesoblast limited

His tone seems very confident about MSB's case regarding the FDA...

  1. 37 Posts.
    lightbulb Created with Sketch. 15
    His tone seems very confident about MSB's case regarding the FDA dispute resolution pathway for accelerated approval - focusing on unmet need and excellent safety profiling of Rem-L. Love it.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.